18:00 IST
BSE
Other Announcement
Trident Texofab Other Announcement
Trident Texofab Limited has appointed M/s. PAAA & Associates as the Cost Auditor for the company, effective September 7, 2026.
Trident Texofab Ltd
- Share price
- ₹20.55
- Market cap
- ₹30.82 Cr
- Revenue (annual)
- ₹118.0 Cr
- Net profit (annual)
- ₹0.70 Cr
- P/E (TTM)
- 146.4×Sector 52.0×
- Promoter holding
- 32.16%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Promoter Buying 4Other Announcement 3Financial Results 3Credit Rating 3Board Meeting Date 3Board Meeting Outcome 2Price Movement Clarification 1Management Change 1Debt & Borrowing 1Capital Structure Change 1Annual General Meeting 1
Time
3 announcements with these filters
20:51 IST
BSE
Other Announcement
Trident Texofab Other Announcement
Trident Texofab Limited has announced the resignation of Shah Kailash & Associates LLP as Statutory Auditor and the appointment of Prit Agrawal & Co as Internal Auditor.
19:04 IST
BSE
Other Announcement
Trident Texofab Other Announcement
Trident Texofab Limited submitted its Annual Secretarial Compliance Report for FY 2025-26. The auditor noted no material non-compliances, indicating robust adherence to SEBI listing regulations.